Le Lézard
Classified in: Science and technology
Subjects: Event, Trade Show

Alida Set to Supercharge Research at Activate 2024


Alida, a leader in user research, today announced it will host its annual global event, Activate, on June 4 and 5, 2024. Research and insights professionals in attendance will learn from industry experts, explore best practices and discover how to connect with the right audiences to make a bigger impact on their organizations.

This year's event will feature keynotes from prominent industry thought leaders Leonard Murphy, Chief Advisor for Insights and Development at Greenbook, Judd Antin, Product and User Experience expert, and Cory Lebson, Principal User Experience Research Consultant at Lebsontech LLC. The event will also showcase best-in-class insights programs from top brands including ADEO, Cabot Creamery, Politico, Volvo Cars, and more.

Sessions at this year's Activate will uncover innovative approaches to tackling today's most pressing issues in user research. The event will equip brands with best practices for collecting and leveraging user insights, empowering them to supercharge their research approach.

"I'm excited to connect with other industry leaders, exchange ideas, and get inspired at Activate," said Murphy. "With today's research landscape evolving rapidly, collaborating and learning from each other is essential. I look forward to sharing more about generative AI and how research teams can get ahead and continue driving meaningful impact in this new world."

The event will also include "Workshop Day", an interactive training day led by Alida industry experts and research professionals including a featured session on UX Research led by Cory Lebson. The workshop will dig deeper into how brands can level up their research programs, get buy-in from stakeholders, and generate more value from their insight efforts.

Additionally, Activate will feature an Alida product session led by Mary Kay Evans, CMO, and Connel O'Reilly, Vice President of Product Management at Alida. This exclusive look at Alida's newest product release will uncover how the newest platform enhancements are empowering researchers with enhanced scale, efficiency, and engagement to support them in effectively managing and engaging with their communities. Among these new features, Alida has launched automated survey translations, simplifying multilingual research initiatives.

To learn more and register for Alida's upcoming Activate event, visit https://www.alida.com/activate-24

About Alida

Alida is a leader in user experience research, enabling the most innovative companies to gather fast and reliable customer feedback at scale. The Alida Research Platform allows organizations to access real users, field a multitude of research methodologies, accelerate analysis, and deliver actionable insights that power product innovation, brand intelligence, and enhanced user experience.

Learn more at www.alida.com.


These press releases may also interest you

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: